Women’s involvement in clinical trials: historical perspective and future implications

2016/03/06 by Katherine A. Liu, Natalie A. DiPietro Mager · 1 citation
Medicine · Social Sciences · Psychology · #Sex and Gender in Healthcare #Diversity and Career in Medicine #Health and Medical Research Impacts #Clinical trial #Inclusion (mineral) #Medicine #Perspective (graphical) #Alternative medicine #Medical prescription #Family medicine #Psychology #Pharmacology #Pathology #Social psychology

paper · pdf · doi:10.18549/pharmpract.2016.01.708

openalex publication_date 2016/03/06 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/03

Abstract

The importance of considering the differences between the male and female sex in clinical decision-making is crucial. However, it has been acknowledged in recent decades that clinical trials have not always adequately enrolled women or analyzed sex-specific differences in the data. As these deficiencies have hindered the progress of understanding women's response to medications, agencies in the United States have worked towards the inclusion of women in clinical trials and appropriate analysis of sex-specific data from clinical trials. This review outlines the history and progress of women's inclusion in clinical trials for prescription drugs and presents considerations for researchers, clinicians, and academicians on this issue.

Citations

• Women’s health and clinical trials
• Adherence to Federal Guidelines for Reporting of Sex and Race/Ethnicity in Clinical Trials

Cited by

• Women's health [wikipedia]

Related

• Gender bias in research: how does it affect evidence based medicine?
• Under-Enrollment of Women in Stroke Clinical Trials
• Inclusion, Analysis, and Reporting of Sex and Race/Ethnicity in Clinical Trials: Have We Made Progress?
• Beyond Binary Policy: Precision Medicine Requires Sex‐Inclusive Research
• significance of sex and gender in clinical pharmacokinetics